1Farley J,Simth LM,Darcy KM,et al.Cyclin E expression is a significant predictor of survival in advanced,suboptimally debulked ovarian epithelial cancers:a gynelologic oncology group study[J].Cancer Res,2003;63(6):1235-1241
2Motokura T,Bloom T,Kim HG,et al.A novel cyclin encoded by a bell-linked candidate oncogene[J].Nature,1991; 350 (6318):512-515
5Zhang J,Li Y,Wang R,et al.Association of cyclin D1 (G870A)polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population[J].Int J Cancer,2003; 105(2):281-284
10Matsuooka S,Edwards MS,Bai C,et al.p57kip2 structurally distinct member of the p21cipl-CDK inhibitor family,is a candicate tumor suppressor gene[J].Gene Dev,1995;9(6):650-662
3Sherr CJ. Cancer cell cycles[J]. Science, 1996, 274: 1672-1677.
4Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinase(CDKs), growth suppressor and cyclin dependent kinase inhibitors(CDKIs) [J]. J Oncogene,1995, 11:211 -219.
5Kamb A. Cell-cycle regulators and cancer[J]. J Trends Genet,1995, 11: 136- 140.
6Ciaparrone M, Yamamoto H, Yao Y, et al. Localization and expression of p27^kipl in multistage colorectal carcinogenesis[J].Cancer Res, 1998, 58:114 - 122.
7Hunter T, Pines J. Cyelins and cancer Ⅱ: Cyclins and CDK inhibitors come of age[J]. Cell, 1994,79:573 -576.
8Clurman BE, Roberts JM. Cell cycle and cancer[J]. J National Cancer Institute, 1995, 87:1499 - 1504.
9Matsuoka S, Edwards MC, Bai C, et al. p57^juo2 a structurally distinct member is a candidate tumor suppressor gene[J]. Genes Dev, 1995, 9:650 - 662.
10Orlow 1, lavarone A, Crider-Miller SJ, et al. Cyclin-dependent kinase inhibitor p57^kip2 in soft tissue sarcoma and Wilms tumor[J].Cancer Res, 1996, 56:1219 - 1221.
